Revised SPC: Rezolsta (darunavir, cobicistat) 800 mg/150 mg film coated tablets

This product is now licensed for use in adolescents aged 12 years and older, weighing ≥40kg (previously adults only). There is also new information on what to do if a patient vomits after taking a dose, interactions with antifungals, and on splitting the tablet.


electronic Medicines compendium